GSK Stock UPDATES Glaxosmithkline Plc (GSK) 47.81 08/21/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Glaxosmithkline Plc (GSK) 47.81 $GSK

Novartis to Invest $35M in Gamida Cell for 15% Equity - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 20, 5:13PM CDT
Novartis (NVS) recently entered into an investment and option agreement with Israel-based Gamida Cell.

GSK receives FDA approval for Arnuity(TM) Ellipta® (fluticasone furoate) in the US for the treatment of asthma
PR Newswire - Wed Aug 20, 2:33PM CDT
GlaxoSmithKline plc today announced that the FDA has approved Arnuity(TM) Ellipta® (fluticasone furoate inhalation powder), a once-daily inhaled corticosteroid (ICS) medicine for maintenance treatment of asthma as prophylactic therapy in patients aged 12 years and older. Arnuity is not indicated for relief of acute bronchospasm.

Why Mylan (MYL) Stock Is Advancing Today
at The Street - Wed Aug 20, 2:01PM CDT
The drug company, along with private equity groups and others, reportedly made it to the second round of bidding for a portfolio of mature drugs being sold by GlaxoSmithKline (GSK).

3 Reasons GlaxoSmithKline plc Stock Could Rise
George Budwell, The Motley Fool - Motley Fool - Wed Aug 20, 11:13AM CDT
Like most big pharmas these days, the U.K.'s  GlaxoSmithKline is going through a transitory period as key medicines like Advair and Lovaza lose market share to new products. Compounding these problems, Glaxo is facing bribery allegations that have...

Eurozone Recovery Stalls in Q2: 3 Stocks to Sell Now - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 20, 8:59AM CDT
Economic growth in the euro area stalled in Q2 with a 0.2% contraction in Germany and Italy sliding to recession.

If You Want Dividend Income, Look No Further than GlaxoSmithKline plc Stock
Sean Williams, The Motley Fool - Motley Fool - Wed Aug 20, 7:44AM CDT
Dividends: They're the cornerstone to any healthy, long-term-focused portfolio. But when it comes to the health care industry, securing dividend income isn't as easy as it sounds. Finding a great dividend involves locating businesses that strike a...

Pernix Therapeutics Closes Acquisition of Treximet. Raises $220m Senior Notes. Issues Updated 2014 Guidance.
Business Wire - Wed Aug 20, 7:01AM CDT
Pernix Therapeutics Holdings, Inc. (NASDAQ GM: PTX) ("Pernix" or the "Company" , a specialty pharmaceutical company, announced today that it has closed its acquisition of Treximet(R) (sumatriptan / naproxen sodium) for the acute treatment of migraine attacks with or without aura in adults. Pernix first announced its agreement with GlaxoSmithKline (NYSE: GSK) to acquire the U.S rights to Treximet(R) on May 14. Pernix's expanded team of approximately 100 specialty sales professionals will support the sales and marketing of Treximet(R). The Company will hold a conference call on Wednesday, August 20 at 9:00 a.m. EDT to discuss this acquisition.

POZEN Announces U.S. Rights For TREXIMET(R) Have Been Acquired by Pernix Therapeutics
Business Wire - Wed Aug 20, 7:00AM CDT
POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, today announced that the acquisition of all of GlaxoSmithKline's (GSK) rights to Treximet(R) (sumatriptan / naproxen sodium) have been acquired by Pernix Therapeutics Holdings, Inc. (Pernix). The previously announced transaction was contingent upon Pernix securing financing, which is now complete. As part of the divestiture, GSK has assigned the Product Development and Commercialization Agreement between POZEN and GSK to Pernix, and POZEN and Pernix have amended the agreement to address rights of the parties and future development.

Poland Healthcare, Regulatory and Reimbursement Landscape Report 2014-2020
M2 - Wed Aug 20, 6:59AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6hf9wd/countryfocus) has announced the addition of the "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Poland" report to their offering. In 2013, Poland's population was estimated at 38.5 million, having grown at a Compound Annual Growth Rate (CAGR) of 0.2% from 2008. It is however expected to decrease to approximately 38.4 million by 2020 due to a drop in the birth rate. The value of the pharmaceutical market in the country amounted to $8.6 billion in 2013, and it is expected to increase at a CAGR of 8.3% to approximately $15 billion in 2020. Generics accounted for the majority of the market in 2012 with a share of 66%. This positive trend can be attributed primarily to the following factors - Government initiatives and support from the EU to improve healthcare services - An improved and updated regulatory environment Scope - An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers - Profiles and SWOT analyses for the major players in the pharmaceutical market (Sanofi, Novartis, GlaxoSmithKline, Polpharma and F. Hoffmann-La Roche) - Profiles and SWOT analyses for the major players in the medical device market (F. Hoffmann-La Roche, Medtronic, Essilor International, Abbott Laboratories and Siemens Healthcare) - An insightful review of the reimbursement and regulatory landscape, including details of the healthcare reimbursement process, regulatory agencies, and approval processes for new drugs and medical devices - Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure, and healthcare expenditure - An overview of the opportunities for and challenges facing growth in the healthcare market Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Overview of the Pharmaceutical and Medical Device Market - Pharmaceutical Market - Medical Device Market - Market Drivers and Barriers 4 Market Access - Reimbursement and Payer Landscape - Regulatory Landscape 5 Country Analysis - Political Environment - Economic Landscape - Economic Indicators - Demographics - Healthcare Infrastructure - Healthcare Expenditure - Trade Associations - Trade Fairs 6 Opportunities and Challenges 7 Appendix For more information visit http://www.researchandmarkets.com/research/6h...untryfocus

North American Pharma-Biotech Sector to Wrap Up Construction on 157 Projects Worth $1.3 Billion in Third-Quarter 2014, an Industrial Info News Alert
Marketwire - Wed Aug 20, 5:15AM CDT
Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Midway through the third quarter of 2014, the Pharmaceutical-Biotech Industry is busy finishing an impressive array of capital construction projects. The sector is on target to complete construction on a total of 156 North American capital projects. A recent survey of reported projects in Industrial Info's Pharmaceutical Tracker - Online Database reveals that the projects represent a total investment value (TIV) of $1.3 billion.

Yes, Call it a Comeback: Amicus Fabry Drug Posts Big Study Win
at The Street - Wed Aug 20, 5:01AM CDT
Based on the positive study results, Amicus intends to seek European approval for migalastat early next year.

PharmaPoint: Seasonal Influenza Vaccines - Global Drug Forecast and Market Analysis to 2022: Event-Driven Update
M2 - Wed Aug 20, 3:51AM CDT
Summary

PharmaPoint: Seasonal Influenza Vaccines China Drug Forecast and Market Analysis
M2 - Wed Aug 20, 3:50AM CDT
Summary

PharmaPoint: Seasonal Influenza Vaccines India Drug Forecast and Market Analysis
M2 - Wed Aug 20, 3:50AM CDT
Summary

PharmaPoint: Seasonal Influenza Vaccines Spain Drug Forecast and Market Analysis
M2 - Wed Aug 20, 3:50AM CDT
Summary

PharmaPoint: Seasonal Influenza Vaccines Japan Drug Forecast and Market Analysis
M2 - Wed Aug 20, 3:50AM CDT
Summary

PharmaPoint: Seasonal Influenza Vaccines Italy Drug Forecast and Market Analysis
M2 - Wed Aug 20, 3:50AM CDT
Summary

PharmaPoint: Seasonal Influenza Vaccines France Drug Forecast and Market Analysis
M2 - Wed Aug 20, 3:40AM CDT
Summary

PharmaPoint: Seasonal Influenza Vaccines United Kingdom Drug Forecast and Market Analysis
M2 - Wed Aug 20, 3:39AM CDT
Summary

PharmaPoint: Seasonal Influenza Vaccines United States Drug Forecast and Market Analysis
M2 - Wed Aug 20, 3:39AM CDT
Summary




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rochester Truck Crashes Demand a Different Liability Map

Updated Category News Views 131

An 80,000-pound rig does not leave anybody the luxury of treating a wreck like a bent-fender dispute. That is the uncomfortable point behind Rochester attorney John Wright's discussion of truck crashes around I-390 and I-490. The physical damage may be obvious, but the legal story can be buried in dispatch systems, maintenance files, driver logs and corporate decisions...

Continue Reading
California Budget Warning Puts Reserves Back in Focus

Updated Category News Views 73

California’s rainy-day umbrella is getting another hard look, and it should. State Controller Malia M. Cohen is pointing to the Legislative Analyst’s Office fiscal outlook as a reminder that budget discipline and stronger reserves are not ornamental good-government phrases. They are the difference between absorbing a revenue wobble and reaching for ugly fixes after...

Continue Reading
illumine Targets Childcare Chain Control and Risk Gaps

Updated Category News Views 90

Expansion Gets Messy Before It Gets Impressive Childcare operators do not usually stumble because they forgot how to care for children; they stumble because the back office fractures as the network grows. One center handles fees one way, another lets enrollment leads work a different funnel, and headquarters discovers too late that its reports are arguing with each other....

Continue Reading
Roof Leaks Demand Diagnosis Before the Repair Bill

Updated Category News Views 83

A brown ring on a ceiling is often the last witness, not the crime scene. That is the useful, unglamorous point in Jonathan Floyd's HelloNation discussion of roof leaks: water has plenty of ways to move after it slips past a roof's defenses. Homeowners understandably stare at the stain and assume the answer sits directly overhead. Sometimes it does. Plenty of times, it...

Continue Reading
Washington-to-Asia Advisory Deal Targets Policy Risk

Updated Category News Views 52

Policy bottlenecks are becoming a cost center across Southeast Asia. That is the plain-English backdrop for the strategic partnership announced November 18, 2026, by Beacon Global Strategies and Vriens & Partners. Neither firm is selling a factory, a chip design, or a new energy project. They are selling something companies increasingly cannot afford to improvise: a...

Continue Reading
Jumia’s Breakeven Retreat Invites Legal Scrutiny

Updated Category News Views 77

Jumia’s credibility problem did not arrive wearing a disguise. The company spent much of 2026 telling investors that a fourth-quarter Adjusted EBITDA breakeven was still on the table, then discarded that target after reporting third-quarter results. For holders of NYSE:JMIA, that kind of reversal stings because the promise was not some stray talking point; it was...

Continue Reading
DigiKey’s Arduino Webinar Puts Edge AI Hardware to Work

Updated Category News Views 68

A Small Board With a Big Practical Question Edge AI is finally getting dragged out of the slide deck and onto the workbench, which is where it ought to prove itself. DigiKey plans to host a free 60-minute webinar on Dec. 2, 2026, at 10 a.m. CST covering Arduino’s new VENTUNO Q edge AI computer. The session promises a hardware tour, an Arduino App Lab walkthrough, and a...

Continue Reading
Disney Springs Hotel Rates Test Holiday Demand Depth

Updated Category News Views 161

A $145 room rate is the sort of holiday bait that gets my attention before the fake snow does. Disney Springs Resort Area Hotels are extending a seasonal offer for stays through Dec. 18, 2026, with bookings open only through Nov. 20. That is a very narrow selling window, and it tells you plenty: these seven independent hotels want to fill rooms during a lucrative but...

Continue Reading
Mining's Biodiversity Map Sharpens Location Risks

Updated Category News Views 117

Twelve thousand pins on a map do not settle the mining industry's nature problem, but they do make it much harder to pretend the problem is evenly spread. ICMM's new Global Mining and Metals Biodiversity Dataset overlays 12,000 large-scale formal mining, smelting, refining and processing facilities with ecosystem-condition and conservation indicators. For investors...

Continue Reading
LEPAS AURA Signals a Sharper Design Bet for Future Cars

Updated Category News Views 145

A porcelain-smooth concept car is not a balance sheet, but it can tell you where a young automotive brand intends to spend its attention. LEPAS unveiled AURA in October at its first Global Elegant Lifestyle Week, presenting it as the brand's first global concept car and a fresh expression of its Leopard Aesthetics design language. That matters because AURA is plainly not...

Continue Reading

Top 5 Most Recently Viewed Articles

Collaboration Amplified: Dental Success Network's New Alliance

Updated Category News Views 93

Collaboration Amplified: Dental Success Network's New Alliance The Dental Success Network (DSN) is excited to announce a partnership with Workvivo, a leading employee communication software, designed to enhance member collaboration and connection within the dental community. Understanding the Importance of Collaboration In today's fast-paced world, collaboration has...

Continue Reading
Quartet Merger Corp. Faces 52-Week Low Amid Market Trends

Updated Category News Views 126

Quartet Merger Corp. Hits 52-Week Low In a year filled with ups and downs, Quartet Merger Corp. (PANL) recently faced a significant setback, marking a new 52-week low at $5.71. This decline is reflective of a broader trend, demonstrating a decrease of nearly 21% in stock value over the past year. Investors are keenly watching how PANL maneuvers through the challenging...

Continue Reading
APi Group's Earnings Preview: Risks and Opportunities Ahead

Updated Category News Views 189

What's Cooking at APi Group? Ah, the ol' earnings report dance. Every quarter it rolls around, and here we are again, with APi Group (NYSE:APG) about to spill its guts on Feb 25, 2026. It's like waiting for your buddy to show up at the bar—some excitement, a tad of anxiety, and maybe a drink to calm the nerves. Analyst predictions put earnings per share (EPS) at around...

Continue Reading
Source Energy Services Prepares for Exciting Q1 Earnings Call

Updated Category News Views 291

Source Energy Services Announces Upcoming Earnings Release CALGARY, Alberta — Source Energy Services is excited to inform its stakeholders that the financial performance results for the first quarter, concluding on March 31, will be shared after the Toronto Stock Exchange closes on the upcoming Thursday, May 8. First Quarter Results and Conference Call Details The...

Continue Reading
FX Market Gears Up for a Dynamic Week Ahead with Central Banks

Updated Category News Views 202

The FX Market Prepares for an Eventful Week The upcoming week promises to be significant for the FX market, as several central banks are set to announce their monetary policy decisions. The European PMI data recently aligned well with market expectations, while the European Central Bank (ECB) opted to keep interest rates steady, attributing this decision to stabilization...

Continue Reading